President And Fellows Of Harvard College

President and Fellows of Harvard College, operating through its Office of Research Administration Division as Harvard Medical School, is a nonprofit educational institution that acts as a prime recipient of federal research grants and a prime contractor on specialized research-services contracts, competing full-and-open without set-aside designations. Harvard Medical School is the research and academic medical enterprise within Harvard University, headquartered in Boston, Massachusetts, under NAICS 611310 (Colleges, Universities, and Professional Schools) and PSC codes spanning laboratory testing, research and development services, and professional support.

Harvard Medical School's federal footprint is dominated by research grants from the National Institutes of Health (NIH). Of 2,486 total awards in the source dataset, the top five customer agencies by award count account for 55% of the portfolio: NIH National Institute of Allergy and Infectious Diseases leads with 189 awards, followed by NIH National Institute of General Medical Sciences (160 awards), NIH National Cancer Institute (151 awards), and NIH National Institute of Neurological Disorders and Stroke (149 awards). Together, NIH and its subordinate institutes represent the overwhelming majority of HMS's federal funding. By potential value, the Defense Advanced Research Projects Agency ranks first at $33.5 million across 22 awards, but this is substantially smaller than the NIH grant pipeline and reflects DARPA's smaller role in HMS's customer mix.

Recent prime work centers on fundamental biomedical research across neuroscience, immunology, cancer biology, and aging. Representative grants include a $3.68 million NINDS award (completed August 2025) investigating neuronal activity-induced immediate-early gene transcription factors in neurodevelopment and synaptic plasticity; a $2.53 million National Eye Institute grant for research on neural and computational mechanisms of natural viewing behavior in primates; and a $2.49 million National Heart, Lung, and Blood Institute award for a longitudinal cohort study of post-tuberculosis lung disease in Lima, Peru. HMS also holds a smaller contract portfolio for specialized research services: a $319,998 Veterans Affairs definitive contract (April 2026) for research subject matter expert services adapting Medicare-quality measures to VA data systems, and several small purchase orders (ranging from $14,000 to $16,139) for laboratory analytical work including nascent transcript analysis and proteome mass spectrometry.

HMS operates as a prime on 92% of awards and as a subcontractor on 8%. In its subcontractor role, HMS delivers specialized research services—including connectomics circuit analysis, machine learning for biomarker prediction, and immunopathology imaging—to prime contractors including Brigham and Women's Hospital, Boston University, Yale University, and the Broad Institute. Across SCI-reportable prime service contracts (FY2023–FY2024), HMS invoiced $2.6 million with a median government-paid hourly rate of $204.05/hr (90th percentile $223.20/hr), delivering roughly 0.7 FTEs in FY2023 and 6.4 FTEs in FY2024. On SCI-reportable prime contracts, subcontractors account for an average of 7% of total contractor hours, with six named subcontractors reported across the small prime-services cohort. HMS does not carry seats on government-wide acquisition vehicles; task orders flow through agency-specific IDIQs such as an NIH indefinite-delivery contract (HHSM500200600015I, three task orders) and a VA contract (VA24113D0088, two task orders).

Activity volume has remained moderate and stable: 119 awards in 2022, declining slightly to 117 in 2023, recovering to 140 in 2024, then settling to 123 in 2025. The source captures only 63 awards year-to-date in 2026, reflecting a partial-year snapshot. Of the 2,486 total awards, 223 face ultimate completion inside the next twenty-four months, carrying combined potential value of $6.8 million and representing modest recompete exposure. HMS's research portfolio spans NAICS categories for colleges and universities, research and development in physical and life sciences, and testing laboratory services; most awards are low-potential-value research project grants typical of NIH funding mechanisms, with combined obligated dollars ($5.13 billion) substantially exceeding combined potential value ($81.4 million) because many grants are fully executed and reported in obligated status.